Showing results (631-640 of 679) with videos related to
Sort By:
Pageof 68
Experimental Hematology|July 26, 2006
Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathwaysZhao Yuan Wang, De Yang, Qian Chen, et al.Clinical Lymphoma, Myeloma & Leukemia|February 27, 2025
Enhancing Multiple Myeloma Care: Implementation of Pharmacist-Led Prescribing of Immunomodulatory Drugs in an Academic Medical SettingAmy Indorf, Mary Kwok, Mark Jao, et al.Frontiers in Cell and Developmental Biology|April 23, 2021
Differential Expression of Insulin-Like Growth Factor 1 and Wnt Family Member 4 Correlates With Functional Heterogeneity of Human Dermal FibroblastsOliver J Culley, Blaise Louis, Christina Philippeos, et al.Journal of Child Neurology|August 27, 2014
Clinical pertinence metric enables hypothesis-independent genome-phenome analysis for neurologic diagnosisMichael M Segal, Mostafa Abdellateef, Ayman W El-Hattab, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 19, 2011
TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protectionIvett Jelinek, Joshua N Leonard, Graeme E Price, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2002
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing miceVincenzo Bronte, Paolo Serafini, Carmela De Santo, et al.Immunobiology|August 1, 1992
Targeting of anti-tumor responses with bispecific antibodiesD M Segal, J H Qian, D Mezzanzanica, et al.International Journal of Clinical & Laboratory Research|January 11, 1992
Bispecific antibodies and retargeted cellular cytotoxicity: novel approaches to cancer therapyJ R Wunderlich, D Mezzanzanica, M A Garrido, et al.Cancer Immunology, Immunotherapy : CII|March 1, 1995
Bispecific antibodies retarget murine T cell cytotoxicity against syngeneic breast cancer in vitro and in vivoM B Moreno, J A Titus, M S Cole, et al.Science (New York, N.Y.)|November 2, 2002
Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2Arya Biragyn, Pier Adelchi Ruffini, Cynthia A Leifer, et al.Pageof 68